FDA Inspection 1120623 — Sionc Pharmaceuticals Private Limited, Unit II
The FDA completed an inspection of Sionc Pharmaceuticals Private Limited, Unit II on February 7, 2020 in Visakhapatnam. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 7, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Visakhapatnam (India)